The powerful effects that ketamine has on the brain’s neurons have led doctors to further explore its medical potential, and now, ketamine infusion therapy and ketamine nasal sprays are giving those with severe depression new hope.
I Use Ketamine for Depression – Here’s How It Works Read More »
The authors’ previous proof of- concept randomized controlled trial of single-dose intravenous ketamine infusion in individuals with PTSD showed significant and rapid PTSD symptom reduction 24 hours postinfusion.
Study: Ketamine for Chronic Posttraumatic Stress Disorder (PTSD) Read More »
In the meantime, practitioners of this new kind of mental healthcare can use ketamine as their psychedelic agent; and some studies, such as the one Grant participated in, are even government funded. The Ketamine for Reduction of Alcoholic Relapse (Kare) study is a novel attempt to ease the huge burden on the NHS caused by alcohol-related illnesses.
Ketamine for Veterans for PTSD Read More »
Elia E. Acevedo-Diaz, Grace W. Cavanaugh, Dede Greenstein, Christoph Kraus, Bashkim Kadriu, Carlos A. Zarate, Lawrence T. Park Published 10 November 2019 | https://doi.org/10.1016/j.jad.2019.11.028 Abstract Background: Concerns about ketamine for treating depression include abuse potential and the occurrence of psychotomimetic effects. This study sought to comprehensively assess side effects (SEs) associated with a single subanesthetic-dose
In the meantime, practitioners of this new kind of mental healthcare can use ketamine as their psychedelic agent; and some studies, such as the one Grant participated in, are even government funded. The Ketamine for Reduction of Alcoholic Relapse (Kare) study is a novel attempt to ease the huge burden on the NHS caused by alcohol-related illnesses.
New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine Read More »
Ketamine has gotten a bad rap as an opioid when there’s plenty of evidence suggesting it isn’t one, Johns Hopkins experts say. They believe this reputation may hamper patients from getting necessary treatment for the kinds of depression that don’t respond to typical antidepressants.
Ketamine Isn’t an Opioid, and it Treats Depression in a Unique Way Read More »
In the meantime, practitioners of this new kind of mental healthcare can use ketamine as their psychedelic agent; and some studies, such as the one Grant participated in, are even government funded. The Ketamine for Reduction of Alcoholic Relapse (Kare) study is a novel attempt to ease the huge burden on the NHS caused by alcohol-related illnesses.
Ketamine for major depression: New tool, new questions Read More »
Off-label and novel treatments continue to be considered for more refractory and disabling cases of PTSD. Ketamine is one such treatment that has been discussed and utilized more often for treatment-resistant major depressive disorder (MDD).
Ketamine as Treatment for Post-Traumatic Stress Disorder: A Review Read More »
Dr. Jennifer Vande Voort, a Mayo Clinic psychiatrist, discusses esketamine nasal spray — a fast-acting treatment for depression that recently was approved by the Food and Drug Administration.
Esketamine Nasal Spray for Depressioin Read More »
Jennifer L. Phillips, Ph.D., Sandhaya Norris, M.D., Jeanne Talbot, M.D., Ph.D., Meagan Birmingham, M.A., M.B.A., Taylor Hatchard, Ph.D., Abigail Ortiz, M.D., Olabisi Owoeye, M.D., Lisa A. Batten, Ph.D., Pierre Blier, M.D., Ph.D. Published Online: 29 Mar 2019 | https://doi.org/10.1176/appi.ajp.2018.18070834 Objective: Subanesthetic ketamine doses have been shown to have rapid yet transient antidepressant effects in patients with